Description
Natural phenolic compound Psoralidin limits cardiotoxicity associated with Doxorubicin
Disciplines
Cardiology | Cardiovascular Diseases | Cellular and Molecular Physiology | Medicinal Chemistry and Pharmaceutics | Medicine and Health Sciences | Oncology | Pharmacology | Therapeutics
Recommended Citation
Shah, Mujtaba H.; Aiges, Myia; and Ramana, Kota V., "Prevention of Doxorubicin-induced cardiotoxicity by a coumestan analogue, Psoralidin" (2023). Annual Research Symposium. 32.
https://ecommons.roseman.edu/researchsymposium/2023/postergroup6/32
Included in
Cardiology Commons, Cardiovascular Diseases Commons, Cellular and Molecular Physiology Commons, Medicinal Chemistry and Pharmaceutics Commons, Oncology Commons, Pharmacology Commons, Therapeutics Commons
Prevention of Doxorubicin-induced cardiotoxicity by a coumestan analogue, Psoralidin
Natural phenolic compound Psoralidin limits cardiotoxicity associated with Doxorubicin